Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Antimicrobial agents in treatment of MRSA infections.

Johnson MD, Decker CF.

Dis Mon. 2008 Dec;54(12):793-800. doi: 10.1016/j.disamonth.2008.09.002. Review. No abstract available.

PMID:
18996282
2.

Treatment of methicillin-resistant Staphylococcus aureus surgical site infections.

Santayana EM, Jourjy J.

AACN Adv Crit Care. 2011 Jan-Mar;22(1):5-12; quiz 14. doi: 10.1097/NCI.0b013e3181ef86fe2049019. Review. No abstract available.

PMID:
21297385
3.

Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.

Loffler CA, Macdougall C.

Expert Rev Anti Infect Ther. 2007 Dec;5(6):961-81.

PMID:
18039081
4.

[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].

Mensa J, Soriano A, Llinares P, Barberán J, Montejo M, Salavert M, Alvarez-Rocha L, Maseda E, Moreno A, Pasquau J, Gómez J, Parra J, Candel J, Azanza JR, García JE, Marco F, Soy D, Grau S, Arias J, Fortún J, de Alarcón CA, Picazo J; Sociedad Española de Quimioterapia (SEQ); Sociedad Española de Medicina Interna (SEMI); GTIPO-Sociedad Española de Anestesiología y Reanimación.

Rev Esp Quimioter. 2013 Jan;26 Suppl 1:1-84. Review. Spanish. No abstract available.

5.

[Staphylococcus aureus and antibiotic resistance].

Sancak B.

Mikrobiyol Bul. 2011 Jul;45(3):565-76. Review. Turkish.

PMID:
21935792
6.

Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.

Twilla JD, Gelfand MS, Cleveland KO, Usery JB.

J Antimicrob Chemother. 2011 Nov;66(11):2675-7. doi: 10.1093/jac/dkr329. Epub 2011 Aug 10. No abstract available.

PMID:
21831987
8.

Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.

Campbell ML, Marchaim D, Pogue JM, Sunkara B, Bheemreddy S, Bathina P, Pulluru H, Chugh N, Wilson MN, Moshos J, Ku K, Hayakawa K, Martin ET, Lephart PR, Rybak MJ, Kaye KS.

Ann Pharmacother. 2012 Dec;46(12):1587-97. doi: 10.1345/aph.1R211. Epub 2012 Dec 4.

PMID:
23212935
9.

Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections.

Ellis MW, Lewis JS 2nd.

Curr Opin Infect Dis. 2005 Dec;18(6):496-501. Review.

PMID:
16258322
10.

In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.

Guo Y, Ramos RI, Cho JS, Donegan NP, Cheung AL, Miller LS.

Antimicrob Agents Chemother. 2013 Feb;57(2):855-63. doi: 10.1128/AAC.01003-12. Epub 2012 Dec 3.

11.

Methicillin-resistant Staphylococcus aureus: the superbug.

Ippolito G, Leone S, Lauria FN, Nicastri E, Wenzel RP.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S7-11. doi: 10.1016/j.ijid.2010.05.003. Epub 2010 Sep 20. Review.

12.

[Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].

Grossi O, Talarmin JP, Boutoille D, Frioux R, Corvec S, Raffi F.

Med Mal Infect. 2008 Dec;38 Spec No 2:10-2. doi: 10.1016/S0399-077X(08)75153-9. French. No abstract available.

PMID:
19185203
13.

Which antibiotic for hospital acquired pneumonia caused by MRSA?

Muscedere J.

BMJ. 2014 Feb 13;348:g1469. doi: 10.1136/bmj.g1469. No abstract available.

PMID:
24525051
14.

New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.

Schmidt-Ioanas M, de Roux A, Lode H.

Curr Opin Crit Care. 2005 Oct;11(5):481-6. Review.

PMID:
16175036
15.

Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?

Gould IM, Cauda R, Esposito S, Gudiol F, Mazzei T, Garau J.

Int J Antimicrob Agents. 2011 Mar;37(3):202-9. doi: 10.1016/j.ijantimicag.2010.10.030. Review.

PMID:
21300528
16.

[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].

Niki Y.

Nihon Naika Gakkai Zasshi. 2012 Apr 10;101(4):1085-91. Review. Japanese. No abstract available.

PMID:
22730740
17.

Treatment of infections caused by resistant Staphylococcus aureus.

Anstead GM, Quinones-Nazario G, Lewis JS 2nd.

Methods Mol Biol. 2007;391:227-58. Review.

PMID:
18025681
18.

[Vancomycin, what else?].

Daurel C, Leclercq R.

Arch Pediatr. 2010 Sep;17 Suppl 4:S121-8. doi: 10.1016/S0929-693X(10)70912-X. French.

PMID:
20826319
19.

Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus.

Yang Y, McBride MV, Rodvold KA, Tverdek F, Trese AM, Hennenfent J, Schiff G, Lambert BL, Schumock GT.

Am J Health Syst Pharm. 2010 Jun 15;67(12):1017-24. doi: 10.2146/ajhp090563.

PMID:
20516473
20.

[Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].

Pangercić A, Bukovski-Simonoski S, Barsić B.

Lijec Vjesn. 2010;132 Suppl 1:11-3. Review. Croatian.

PMID:
20715711

Supplemental Content

Support Center